Biomarkers of aging are measurable indicators that reflect biological age and aging processes. These markers are essential for evaluating the effectiveness of longevity interventions and understanding individual aging trajectories.

Aging biomarkers provide objective measures of biological age that may differ from chronological age. They help assess the effectiveness of interventions and predict health outcomes.
The Horvath clock, based on DNA methylation patterns, has been validated across multiple tissues and shows strong correlation with chronological age and health outcomes.[1] The PhenoAge clock incorporates clinical biomarkers and has been shown to predict mortality better than chronological age.[2]
Biomarkers are used for:
Current limitations include:
Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115. https://genomebiology.biomedcentral.com/articles/10.1186/gb-2013-14-10-r115 ↩︎
Levine ME, Lu AT, Quach A, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10(4):573-591. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940111/ ↩︎